1996
DOI: 10.1016/s0022-3468(96)90478-9
|View full text |Cite
|
Sign up to set email alerts
|

OK-432 therapy for lymphangioma in children: Why and how does it work?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
137
1
23

Year Published

1999
1999
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 216 publications
(164 citation statements)
references
References 13 publications
3
137
1
23
Order By: Relevance
“…Many adjunctive therapies for treatment of lymphangioma have been described with varying results. Successful outcomes have been reported following the use of intralesional Bleomycin, sclerotherapy with OK432 or percutaneous embolization with Ethibloc [15][16][17] . Local injection of fibrin glue and laser photocoagulation have been used for postnatal treatment 18,19 .…”
Section: Discussionmentioning
confidence: 99%
“…Many adjunctive therapies for treatment of lymphangioma have been described with varying results. Successful outcomes have been reported following the use of intralesional Bleomycin, sclerotherapy with OK432 or percutaneous embolization with Ethibloc [15][16][17] . Local injection of fibrin glue and laser photocoagulation have been used for postnatal treatment 18,19 .…”
Section: Discussionmentioning
confidence: 99%
“…The streptococcus preparations can activate natural killer cells and T cells, as well as inducing the production of cytokines such as tumor necrosis factor, interleukin-6, vascular endothelial growth factor and transforming growth factor β 1 . Therefore, the intrathoracic injection of these agents promotes the development of fibrin clots, and this is thought to facilitate pleurodes (Ogita et al, 1996;Fujino et al, 2003). Sapylin/OK-432 produces an inflammatory reaction leading to the destruction of the epithelial lining and the subsequent sclerosis and cicatricial contraction of the lesion, too.…”
Section: Discussionmentioning
confidence: 99%
“…Ethanol was the most common sclerosing agent used in the past, followed by doxycycline, sodium tetradecyl sulfate (STS), 40 and OK-432. 41 Response varied with the type of lymphatic malformation, with 100%, 86%, and 43% of the patients reporting good to complete response for macrocystic, microcystic, and combined-type lymphatic malformations, respectively.…”
Section: Treatment Of Lymphatic Malformationsmentioning
confidence: 99%